ALNY
Alnylam Pharmaceuticals, Inc. · Healthcare
CEO John Maraganore sold $4.4M of Alnylam Pharmaceuticals, Inc.
Sold$4,443,725
$130.78Price
33,979Shares
−13%Stake
What ALNY did after the filing
- The stock from Tue, May 18 open, $135.39
- +25.2%
- S&P 500, same days
- +3.3%
Measured over 30 trading days, to the Jun 30 close.
Traded Thu, May 13. Filed Mon, May 17, 7:25 PM ET, after the close. Returns use the May 18 open and the Jun 30 close. Not investment advice.